| Purposes: Under the background of constructing an innovative country in China,researching the present capability of original and collaborative innovation in Jiangsu's pharmaceutical manufacturing industry from view of micro enterprises;measuring the Jiangsu's pharmaceutical manufacturing efficiency of original innovation from the point of industry and cities;analyzing the significant influence factors to original innovation ability of Jiangsu's pharmaceutical manufacturing industry.From the perspective of knowledge spillover and the absorptive capacity,evaluate the ability of collaborative innovation of pharmaceutical manufacturing production in Jiangsu province.Comprehensive evaluation the innovation ability and specifically reflecting the existence problems of various types of industries and regions and puts forward the path of the pharmaceutical manufacturing industry innovation ability in Jiangsu province and policy recommendations according to the division of different types.Objects and Methods: Based on Jiangsu province pharmaceutical manufacturing microeconomic data from 2012 to 2015,from divisions and cities in two aspects,use two stage SBM model based on DEA method and Malmquist index model to analyze and evaluate the efficiency of the original independent innovation ability as well as the development trend,and according to the two aspects of the efficiency of technology innovation and achievements transformation ability establish original innovation industry and cities can be divided into technical efficiency matrix A,B,C,D four categories,pharmaceutical manufacturing using Tobit regression analysis the original innovation ability of external influence factors;Using the principal component analysis(PCA)to evaluate the collaborative innovation capability of pharmaceutical manufacturers in Jiangsu and use the econometrics method of panel data regression analysis of the influence factors in the process of collaborative innovation.Results:(1)The technical efficiency of the technological development stage of the pharmaceutical manufacturing industry in Jiangsu province showed a wave pattern,and the peak value was in 2014.The technical efficiency of the transformation stage is generally higher than that of the technology development stage.The original innovation efficiency of the two industries is relatively strong compared with other industries,and the innovation efficiency of Chinese patent medicine is relatively weak compared with other industries.Taizhou,Zhenjiang,Nantong and other cities have maintained high technological innovation efficiency in the two stages of original innovation,and the innovation efficiency of Huai'an and Yancheng is low.(2)The market structure,the ownership structure of the enterprise and the size of the enterprise have great influence on the original innovation ability of Jiangsu pharmaceutical manufacturing industry as a whole.(3)Taizhou,Lianyungang,Changzhou maintained a higher level of production,collaborative innovation capability,Suqian,Zhenjiang,knowledge spillover effect is not obvious technology absorption capacity is not strong in these area,the overall synergy innovation ability is weak;(4)The quantity of personnel and research investment have great influence f on the collaborative innovation ability of middle region in Jiangsu,research cooperation with domestic colleges and universities makes north Jiangsu a great improvement of enterprise innovation output effect,it is obvious that the largest pharmaceutical companies in the southern areas of Jiangsu collaborate with overseas R&D to improve their innovation ability.Suggestions:(1)The organization leadership,strengthening the legislation on the original innovation and collaborative innovation,deepen reform and improve the implementation of preferential policies on innovation,establish and improve the communication and coordination among universities,research institutions and enterprises organization,play to the pharmaceutical industry association and other social organizations of social service function.(2)The system mechanism innovation:build long-term effective mechanism of the pharmaceutical manufacturing industry innovation,the pharmaceutical industry innovation system mechanism,to attract high-level pharmaceutical R&D talents cultivating mechanism,formation of preferential tax platform based on different forms of innovation.(3)Specific measures: select the effective path of innovation efficiency and promote the agglomeration of pharmaceutical industry;Establishing a benign competitive market environment,appropriately expanding the scale of pharmaceutical enterprises;To strengthen the absorption capacity of imported technology and stimulate the innovation enthusiasm of R&D staff;To strengthen the flow of talents among regions,to establish and perfect the introduction and training mechanism of R&D talents;Improve collaborative innovation network organization model;Establish a cross-regional industrial cluster collaborative innovation system which is in line with the characteristics of Jiangsu pharmaceutical manufacturing industry. |
PDF Full Text Request